Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (127)	6/24/2003 4:21:33 PM
From: keokalani'nui	Read Replies (1) \| Respond to of 566

Rigel Announces 1 for 9 Reverse Stock Split Tuesday June 24, 4:10 pm ET SOUTH SAN FRANCISCO, Calif., June 24 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL - News) today effected a 1-for-9 reverse stock split of its outstanding common stock, after its stockholders approved the proposal for a reverse split at the Company's annual meeting of stockholders held on June 20, 2003. Rigel's common stock will begin trading on Nasdaq on a reverse split basis as of the opening of trading on June 25, 2003. For a period of 20 trading days, shares of Rigel's common stock will trade under the ticker "RIGLD." After 20 trading days, trading will resume under the ticker "RIGL". Holders of Rigel's common stock will receive instructions by mail regarding the method of exchanging pre-split stock certificates for post-split certificates and they will be entitled to receive one newly-issued share of common stock for each 9 shares held as of June 24, 2003. Stockholders need not do anything with their share certificates until they receive such instructions. Wells Fargo Shareowner Services of St. Paul, Minnesota is Rigel's transfer agent and will act as the exchange agent for the purpose of implementing the exchange of stock certificates in relation to the reverse stock split.